WaveMan
WaveMan · Company
BUDZ · Weed, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

BUDZ Weed (BUDZ) Insider Trading, Ownership & Congress Trades

Pharma & Biotech · Services-commercial physical & biological research · CIK 0001393772
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about BUDZ

Insiders, 180 days
-$31.5K net sold
1 seller · 0% of sales under a 10b5-1 plan

Weed insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, WEED, INC. insiders sold a net $31.5K of stock across 72 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
BREEN NICOLE M
Secretary and Treasurer
SELL
2026-10-23 SECtraded 2026-09-28
60,000
$1.8K
-27.0%
Context
  • 71 earlier Form 4 trades (code P or S) here by this insider (71 sales), the last on Sep 10, 2026.
  • The trade is 0.2% of the 29,749,930 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Secretary and Treasurer BREEN NICOLE M sold about $1.8K of BUDZ on Sep 28, 2026.
BREEN NICOLE M
Secretary and Treasurer
SELL
2026-10-23 SECtraded 2026-09-10
10,000
$300
-27.0%
Context
  • 70 earlier Form 4 trades (code P or S) here by this insider (70 sales), the last on Sep 8, 2026.
  • The trade is 0.0% of the 29,809,930 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Secretary and Treasurer BREEN NICOLE M sold about $300 of BUDZ on Sep 10, 2026.
BREEN NICOLE M
Secretary and Treasurer
SELL
2026-10-23 SECtraded 2026-09-08
50,000
$1.5K
-27.0%
Context
  • 69 earlier Form 4 trades (code P or S) here by this insider (69 sales), the last on Aug 18, 2026.
  • The trade is 0.2% of the 29,819,930 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Secretary and Treasurer BREEN NICOLE M sold about $1.5K of BUDZ on Sep 8, 2026.
BREEN NICOLE M
Secretary and Treasurer
SELL
2026-08-21 SECtraded 2026-08-18
50,000
$1.5K
-51.3%
Context
  • 68 earlier Form 4 trades (code P or S) here by this insider (68 sales), the last on Aug 13, 2026.
  • The trade is 0.2% of the 29,869,930 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Secretary and Treasurer BREEN NICOLE M sold about $1.5K of BUDZ on Aug 18, 2026.
BREEN NICOLE M
Secretary and Treasurer
SELL
2026-08-21 SECtraded 2026-08-13
80,000
$20.0K
-51.3%
Context
  • 67 earlier Form 4 trades (code P or S) here by this insider (67 sales), the last on Aug 7, 2026.
  • The trade is 0.3% of the 29,919,930 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Secretary and Treasurer BREEN NICOLE M sold about $20.0K of BUDZ on Aug 13, 2026, the largest insider sale at the company on our record.
72 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 67 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$31.5K over 180 days
-$28.1K over 90 days · -$31.5K of it by a 10%+ holder
more than 58% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
0.2% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
below 90% of Pharma & Biotech
What changed in the last 30 days
Oct 23Secretary and Treasurer BREEN NICOLE M sold $3.6K (3 trades, Sep 8 to Sep 28)

Watch BUDZ

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-63.5%12M
-75%-25%+25%+75%2025-102025-122026-022026-042026-062026-082026-10 2026-08-13 · BREEN NICOLE M sold $20.0K2026-05-06 · BREEN NICOLE M sold $3.2K2026-02-04 · BREEN NICOLE M sold $2.4K2026-09-28 · BREEN NICOLE M sold $1.8K2026-01-22 · BREEN NICOLE M sold $1.5K2026-08-06 · BREEN NICOLE M sold $1.5K2026-08-07 · BREEN NICOLE M sold $1.5K2026-08-18 · BREEN NICOLE M sold $1.5K2026-09-08 · BREEN NICOLE M sold $1.5K2026-02-02 · BREEN NICOLE M sold $1.3K2026-02-03 · BREEN NICOLE M sold $1.2K2026-02-11 · BREEN NICOLE M sold $1.1K2026-02-12 · BREEN NICOLE M sold $1.1K2026-09-10 · BREEN NICOLE M sold $3002026-05-29 · BREEN NICOLE M sold $2002026-05-08 · BREEN NICOLE M sold $22026-07-01 · BREEN NICOLE M filed to sell $32.6K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns BUDZ: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in BUDZ

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

BUDZ planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
BREEN NICOLE M
Filed 2026-07-01
$32.6K
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $31.5K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLTWST

BUDZ financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$0
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Free cash flow, TTM
-$201.1K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
n/a
average equity is zero or negative
Return on assets
-209.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
n/a
capital employed is zero or negative
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no debt line filed
FCF yield
-9.3%
TTM free cash flow over market value at close 2026-10-27
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$0$0$0$0
Gross profit$0$0$0$0
Operating income-$1.3M-$530.0K-$770.6K-$1.5M
Net income-$1.4M-$510.7K-$31.6K-$1.5M
EPS (diluted)-0.01-0.00-0.00n/a
Operating cash flow-$195.1K-$415.5K-$1.1M-$813.0K
SEC XBRL, fiscal years, as known on 2026-10-28

BUDZ Stock Sonar score 2/7 axes

Find similar shapesCompare
Insider conviction
28
Inputs
  • Net Form 4 buying (codes P and S), 180d-$31K · 57 pct, sector of 429
  • Insider buyers, 180d0 · 0 pct, sector of 438
Risk and compliance
91
Inputs
  • Short interest, % of float+0.2% · 91 pct, sector of 816
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
5 not measured: Profitability, Financial health, Growth, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; pre-tax loss, no effective tax rate to apply
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

BUDZ filings, in plain words

Are Weed insiders buying or selling BUDZ?

In the 180 days to 2026-10-28, Weed insiders were net sellers, a net $31.5K across purchases and sales reported on Form 4, by 1 seller.

Read the full summary

In the 180 days to 2026-10-28, Weed insiders were net sellers of BUDZ, a net $31.5K across purchases and sales reported on Form 4 by 1 seller. Most of that figure, $31.5K, came from a holder of 10% or more rather than an officer or director. None of the 10 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies